According to Egetis Therapeutics AB's latest financial reports the company's current revenue (TTM ) is $6.74 Million USD. In 2025 the company made a revenue of $6.59 Million USD an increase over the revenue in the year 2024 that were of $4.35 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.